Nuvilex, Inc.

Nuvilex Inc., through its subsidiaries, engages in the research, development, and marketing of nutraceutical products in the United States and internationally. It has researched and developed a range of whole foods and nutraceutical products to help improve various health conditions, including glucose metabolism, scarring, acne, cholesterol, common cold, influenza, and other known pathogens, such as staphylococcus and streptococcus.
It also offers Citroxin, a surface cleaner and an antiviral composition against swine influenza virus and avian influenza viruses; Cinnechol, a nutritional supplement to maintain normal cholesterol levels, as well as to support normal cardiovascular function; Cyclesurface3 cosmetics, a lipophilic surface treatment technology that is used to improve the dispersion of pigments in aqueous and organic materials; and Infinitink, a removable tattoo ink.
Contact Details
Executives
Chairman, President, and CEO
Martin E. Schmieg
SVP, CFO, Secretary, and Director
Blair Barnes